Kerafast

Founded in 2011, Kerafast is a life science reagent company focused on improving access to laboratory-developed research tools originating from academic institutions, research centres and biotechnology laboratories. The company works with scientists to make specialised reagents available through a streamlined distribution model, supporting the exchange of materials that can otherwise be difficult to obtain. Its portfolio enables researchers to advance studies in cell biology, immunology, infectious diseases, virology, cancer research, neuroscience, molecular biology and protein expression. By facilitating access to validated research materials, Kerafast supports experimental reproducibility and the translation of scientific discoveries into broader research applications.

Kerafast offers a diverse range of research-use products including antibodies, cell lines, recombinant proteins, expression plasmids, small molecules, probes, dyes and microbial strains. The catalogue includes widely used academic reagents such as anti-dsRNA and anti-DNA/RNA hybrid antibodies, specialised viral research tools, cell culture models and protein expression systems. These products support workflows spanning biomarker discovery, pathogen research, gene expression studies, antibody development, translational research and cell-based assays.

Europa Biosite subsidiaries distribute Kerafast products to researchers across Austria, Belgium, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the UK.